WELCOME TO The Biotechnology REPORT
Newsletter | Member Login | Signup
Home > Resources > Whitepapers > Next Generation Therapies and related Life Sciences topics
January 16, 2022
I'm For Real
Enter your details once to access all our information and resources
Selvita is an integrated service provider aiming to deliver a set of comprehensive solutions supporting customers and projects within area of drug discovery, regulatory studies, as well as research and development.
whitePaper | October 27, 2022
The cell and gene therapy (CGT) market is rapidly transitioning from ultra-niche cutting-edge science to approved and available therapies that can address previously intractable and often devastating diseases.
whitePaper | March 18, 2022
Fungi are usually seen by the wood used only as destroyers or parasites. Material infestation should be avoided as far as possible for wood preservation reasons.
whitePaper | December 13, 2022
Define the ongoing pandemic of antimicrobial resistance. Discuss how we can address the ongoing pandemicin the Clinical Microbiology Laboratory
whitePaper | June 8, 2022
Sequencing of human genomes is fast becoming an affordable technology for general consumer.
whitePaper | April 14, 2021
Delivering Covid-19 vaccines to 7.8 billion people is a daunting challenge that will stretch supply chains past their limits. Even if all the needed doses were ready today, vaccine manufacturers still must find solutions to deliver multiple doses of those vaccines to most people on the planet. To read more, please download this free white paper.
whitePaper | March 16, 2023
Biopharma focuses on streamlining biomanufacturing and supply chain issues to drive uptake of cell and gene therapies.
Keep me plugged in with the best
Join thousands of your peers and receive our weekly newsletter with the latest news, industry events, customer insights, and market intelligence.
Welcome back!
Put your news, events, company, and promotional content in front of thousands of your peers and potential customers.
Not a member yet? Not a problem, Sign Up
Sign up
Sign up to contribute and publish your news, events, brand, and content with the community for FREE